Arzeda Raises $38M Oversubscribed Round from Sofinnova, Fall Line, Sucden, Silver Blue and W.L. Gore to Scale ProSweet and Commercialize Designer Proteins
Arzeda raised $38M in an oversubscribed round led by new investors including Sofinnova Partners, Fall Line Capital, Sucden Ventures, Silver Blue, and W.L. Gore’s venture arm to scale ProSweet stevia enzyme production and speed commercialization of additional designer proteins.
No comments yet.